Cell · 2015
Chromothriptic cure of WHIM syndrome.
Клинический случайСтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
McDermott David H, Gao Ji-Liang, Liu Qian, Siwicki Marie, Martens Craig, Jacobs Paejonette, Velez Daniel, Yim Erin, Bryke Christine R, Hsu Nancy, Dai Zunyan, Marquesen Martha M, Stregevsky Elina, Kwatemaa Nana, Theobald Narda, Long Priel Debra A, Pittaluga Stefania, Raffeld Mark A, Calvo Katherine R, Maric Irina, Desmond Ronan, Holmes Kevin L, Kuhns Douglas B, Balabanian Karl, Bachelerie Françoise, Porcella Stephen F, Malech Harry L, Murphy Philip M
Аннотация
Chromothripsis is a catastrophic cellular event recently described in cancer in which chromosomes undergo massive deletion and rearrangement. Here, we report a case in which chromothripsis spontaneously cured a patient with WHIM syndrome, an autosomal dominant combined immunodeficiency disease caused by gain-of-function mutation of the chemokine receptor CXCR4. In this patient, deletion of the disease allele, CXCR4(R334X), as well as 163 other genes from one copy of chromosome 2 occurred in a hematopoietic stem cell (HSC) that repopulated the myeloid but not the lymphoid lineage. In competitive mouse bone marrow (BM) transplantation experiments, Cxcr4 haploinsufficiency was sufficient to confer a strong long-term engraftment advantage of donor BM over BM from either wild-type or WHIM syndrome model mice, suggesting a potential mechanism for the patient's cure. Our findings suggest that partial inactivation of CXCR4 may have general utility as a strategy to promote HSC engraftment in transplantation.